Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 2, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Cara L Slagle1, Kim T Vuong2, Kelli A Krallman3
1Division of Neonatology, Riley Hospital for Children at Indiana University Health and Indiana University College of Medicine, Indianapolis, IN; Neonatology and Pulmonary Biology, Cincinnati Children's Hospital Medical Center & University of Cincinnati College of Medicine, Cincinnati, OH; Center for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Survival for infants receiving continuous renal replacement therapy (CRRT) with the Carpediem system exceeded 60% in a US study. The primary use of CRRT was for end-stage kidney disease (ESKD) in infants.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: